Apple Seeks Deal With Blacklisted Chinese Chipmaker CXMT
In a high-stakes move to mitigate the ongoing global memory chip crisis, Apple is currently lobbying the Trump administration for special permission to source components from ChangXin Memory Technologies (CXMT), a Chinese memory chip manufacturer currently blacklisted by the Pentagon. According to reports from the Financial Times, the tech giant is attempting to navigate complex geopolitical waters to secure a supply chain that has been severely disrupted by the massive shift toward artificial intelligence infrastructure. As major global manufacturers prioritize high-margin HBM chips for data centers, consumer electronics face unprecedented shortages, forcing Apple to explore risky partnerships to stabilize its production costs and inventory levels.
- Apple is requesting regulatory clearance to partner with the Pentagon-blacklisted Chinese firm CXMT to alleviate memory supply shortages.
- The shift of major memory suppliers toward AI-focused HBM production has created a significant global deficit of traditional DRAM chips.
- Apple has recently implemented substantial price increases across its MacBook and iPad lineups due to rising manufacturing costs.
- The company is seeking guarantees from Washington that a potential partnership with CXMT will not lead to more severe sanctions under the Entity List.
Memory Shortages Have Cornered Apple
The tech industry is currently experiencing a massive reallocation of resources as companies pour hundreds of billions of dollars into AI infrastructure. Industry leaders such as Micron, Samsung, and SK Hynix are shifting their production capacity toward high-bandwidth memory chips, which offer significantly higher profit margins. This strategic pivot has resulted in a severe shortage of the traditional DRAM chips required for mainstream consumer electronics like smartphones and laptops.
The inability to secure sufficient components has forced Apple to pass the burden of increased costs directly onto its global customer base.
The impact of this scarcity was recently made evident in Apple’s pricing strategy. CEO Tim Cook has acknowledged the unprecedented rise in production costs, which has led to immediate price hikes for several flagship devices. The 1 TB M5 MacBook Pro saw a $300 price increase, while the entry-level MacBook Neo model rose by $100. Furthermore, new iPad Pro models have become $200 more expensive compared to just last week. 
These adjustments highlight the unsustainable pressure currently placed on Apple’s supply chain.
Pentagon’s 1260H List Complicates Negotiations
ChangXin Memory Technologies (CXMT) stands as China’s largest DRAM producer and is actively seeking to expand its market presence. However, the company is listed on the Pentagon’s 1260H list, which identifies entities allegedly linked to the Chinese military. While this designation does not strictly prohibit private companies from engaging in trade, it presents a substantial reputational risk and prevents any direct collaboration with the U.S. Department of Defense.
Apple is specifically concerned that the U.S. Department of Commerce might move CXMT to the more restrictive Entity List if a deal is formalized.
To mitigate this threat, Apple is lobbying officials to receive assurances that any new partnership with the Chinese manufacturer will not be met with further punitive measures. This is not the first time the company has faced such dilemmas; in 2022, Apple abandoned plans to source components from YMTC following intense political pressure. However, the current depth of the chip crisis is pushing the company to take greater risks. The technology and financial sectors are now closely watching to see how the Trump administration will respond to this sensitive request.
Given the ongoing tension between global technological independence and supply chain necessity, do you believe Apple should prioritize its production costs over national security concerns? Share your perspective in the comments section below.
Your comment has been submitted,
it will be published after approval.